tiprankstipranks
Trending News
More News >
Otsuka Corporation (JP:4768)
:4768

Otsuka (4768) AI Stock Analysis

Compare
1 Followers

Top Page

JP

Otsuka

(OTC:4768)

Rating:71Outperform
Price Target:
¥3,232.00
▲(10.25%Upside)
Otsuka demonstrates a strong financial performance with solid revenue growth and a well-managed balance sheet, which is the primary factor driving the score. However, the bearish technical indicators and moderate valuation suggest caution. The absence of earnings call insights or corporate events leaves room for uncertainty in forward guidance.

Otsuka (4768) vs. iShares MSCI Japan ETF (EWJ)

Otsuka Business Overview & Revenue Model

Company DescriptionOtsuka Corporation provides system integration, support, and other services in Japan. The System Integration Business segment offers system services, including consulting, system design and development, transport and installation work, and network construction. It also provides management systems and collaborative software, such as ERP packages and groupware to cover a range of specialized fields, including CAD and web technologies; and software, hardware, intranet, and security products for the construction and expansion of computer networks. In addition, this segment sells computers, copiers, and communications equipment and software; and develops consigned software. The Service and Support Business segment offers supplies, hardware and software maintenance, telephone support, and outsourcing services; emergency computer rescue services for corporate and individual clients; and network support and services for the planning, design, construction, and operation of corporate information systems, as well as out-sources system engineers. It also provides educational support services. The company was founded in 1961 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyOtsuka makes money through multiple revenue streams primarily derived from its pharmaceuticals and nutraceuticals divisions. In the pharmaceuticals sector, the company generates revenue by developing and selling prescription medications, with a strong emphasis on central nervous system disorders and oncology. Key products include antipsychotic medications and cancer treatments. The nutraceuticals division contributes to the company's earnings by offering health and wellness products, such as electrolyte drinks and nutritional supplements, directly to consumers. Otsuka also benefits from strategic partnerships and collaborations with other pharmaceutical companies and research institutions, expanding its market reach and leveraging shared resources for product development. The company invests significantly in research and development to maintain a robust pipeline of new products, ensuring long-term revenue growth.

Otsuka Financial Statement Overview

Summary
Otsuka's financial health is robust, characterized by strong revenue growth and profitability, a solid balance sheet with low leverage, and consistent cash flow generation. The company is well-positioned in the Technology Distributors industry, with effective cost management and a strong equity position. However, attention should be paid to the increasing liabilities to ensure long-term stability.
Income Statement
85
Very Positive
Otsuka exhibits strong revenue growth with a 13.3% increase from 2023 to 2024, driven by consistent gross profit margins around 20%. The net profit margin improved to 4.8% in 2024 from 4.9% in 2023, indicating strong control over costs and expenses. The EBIT and EBITDA margins remain robust at 6.7% and 7.5% respectively, reflecting operational efficiency.
Balance Sheet
80
Positive
The balance sheet is solid with a low debt-to-equity ratio of 0.02, indicating minimal leverage. The return on equity is commendable at 14.4%, demonstrating effective use of equity capital. The equity ratio stands at 55.0%, showing a strong equity base. However, the growth in total liabilities suggests potential risk if not managed properly.
Cash Flow
78
Positive
Cash flow performance is stable with an operating cash flow to net income ratio of 0.71, indicating strong cash generation relative to profits. Free cash flow decreased but remains positive, ensuring liquidity. The free cash flow to net income ratio is 0.65, showcasing healthy cash conversion.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
1.16T1.11T977.37B861.02B851.89B836.32B
Gross Profit
230.98B224.47B203.98B184.17B176.89B173.72B
EBIT
78.29B74.36B62.96B54.77B55.83B56.31B
EBITDA
88.15B82.65B72.86B63.06B63.81B63.92B
Net Income Common Stockholders
56.29B53.48B47.45B40.02B39.93B39.31B
Balance SheetCash, Cash Equivalents and Short-Term Investments
199.54B228.14B228.69B202.29B204.70B178.07B
Total Assets
685.99B673.90B561.80B523.02B486.25B471.29B
Total Debt
6.00B6.86B7.30B7.51B7.99B8.02B
Net Debt
-193.54B-221.28B-221.39B-194.78B-196.72B-170.05B
Total Liabilities
325.29B298.66B214.85B200.29B184.48B191.26B
Stockholders Equity
356.34B370.80B343.11B319.39B298.74B277.35B
Cash FlowFree Cash Flow
12.71B34.49B61.30B22.12B46.99B23.63B
Operating Cash Flow
17.99B37.71B71.65B29.20B57.87B32.50B
Investing Cash Flow
-14.16B-11.95B-21.47B-8.36B-9.16B-8.72B
Financing Cash Flow
-30.66B-25.89B-23.84B-23.31B-21.96B-20.99B

Otsuka Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2931.50
Price Trends
50DMA
3027.92
Negative
100DMA
3224.85
Negative
200DMA
3352.90
Negative
Market Momentum
MACD
-25.24
Negative
RSI
43.78
Neutral
STOCH
44.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4768, the sentiment is Negative. The current price of 2931.5 is below the 20-day moving average (MA) of 2933.58, below the 50-day MA of 3027.92, and below the 200-day MA of 3352.90, indicating a bearish trend. The MACD of -25.24 indicates Negative momentum. The RSI at 43.78 is Neutral, neither overbought nor oversold. The STOCH value of 44.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4768.

Otsuka Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$1.11T19.7516.17%2.58%15.49%18.42%
62
Neutral
$11.80B10.37-7.29%2.91%7.39%-7.96%
DE9V2
€886.47M8.0010.70%4.27%
80
Outperform
¥54.98B8.74
2.31%11.02%65.66%
80
Outperform
¥235.10B9.11
3.64%17.47%492.18%
76
Outperform
¥69.27B10.13
3.33%7.56%12.07%
74
Outperform
¥81.44B16.75
1.51%6.46%67.90%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4768
Otsuka
2,931.50
84.39
2.96%
DE:9V2
Kaga Electronics Co., Ltd.
15.90
-0.04
-0.25%
JP:3107
Daiwabo Holdings Co., Ltd.
2,472.00
-197.02
-7.38%
JP:6638
Mimaki Engineering Co., Ltd.
1,843.00
-90.05
-4.66%
JP:7513
Kojima Co., Ltd.
1,056.00
181.25
20.72%
JP:9824
Senshu Electric Co., Ltd.
4,205.00
-772.37
-15.52%

Otsuka Corporate Events

Otsuka Corporation Reports Strong Q1 2025 Financial Results
Apr 30, 2025

Otsuka Corporation reported strong financial results for the first quarter of 2025, with a notable increase in net sales and profits compared to the previous year. The company’s performance reflects its robust market positioning and strategic initiatives, which have positively impacted its financial health and stakeholder confidence.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.